Navigation Links
Shareholder Class Action Filed Against GPC Biotech AG by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
Date:8/23/2007

RADNOR, Pa., Aug. 23 /PRNewswire/ -- The following statement was issued today by the law firm of Schiffrin Barroway Topaz & Kessler, LLP:

Notice is hereby given that a class action lawsuit was filed in the United States District Court for the Southern District of New York on behalf of all purchasers of securities of GPC Biotech AG (Nasdaq: GPCB) ("GPC" or the "Company") from December 5, 2005 through July 24, 2007, inclusive (the "Class Period").

If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Schiffrin Barroway Topaz & Kessler, LLP (Darren J. Check, Esq. or Richard A. Maniskas, Esq.) toll free at 1-888-299-7706 or 1-610-667-7706, or via e-mail at info@sbtklaw.com.

The Complaint charges GPC and certain of its officers and directors with violations of the Securities Exchange Act of 1934. GPC is a biopharmaceutical company engaged in the discovery, development and commercialization of new drugs to treat cancer. More specifically, the Complaint alleges that the Company failed to disclose and misrepresented the following material adverse facts which were known to defendants or recklessly disregarded by them: (1) that the U.S. Federal Drug Administration ("FDA") had previously expressed disapproval regarding the Company's choice of methodology and a primary endpoint in the satraplatin studies; (2) that the Company continued to evaluate satraplatin using the disputed endpoint; (3) that the Company disregarded the FDA's previously expressed concerns about the disputed primary endpoint, and submitted the satraplatin study results to the FDA with the disputed primary e
'/>"/>

SOURCE Schiffrin Barroway Topaz & Kessler, LLP
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Doyle repeals shareholder liability
2. Why repealing the shareholder wage lien law makes sense
3. Merge president steps down in wake of shareholder suits
4. Pressure mounts for Doyle to repeal shareholder liability law
5. Merges merger is the crux of shareholder lawsuits
6. RNase Activity in Mouse Tissue: Classification, Hierarchy, and Methods for Control
7. Screening and classifying hazardous waste samples
8. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
9. Early Stage, Step 8: Misclassifying workers brings risk
10. Healthcare software addresses "90 million" misclassified Americans
11. Classroom projects translate into immediate workplace gains
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2009)...VANSE is the first stimulant to establish duration...dministration in adults with ADHD , , HOLLYWOOD... (LSE: SHP, Nasdaq: SHPGY ), the global specialt...ts from a Phase 3b study that found VYVANSE(R) (li...icant efficacy at 14 hours after administration du...
(Date:7/1/2009)...STIN, Calif., July 1 Per...ay announced that it has been awarded a European p...iological agents to labels for diagnostic and ther...own as In-Line labeling, was developed for the pro...t is applicable to other agents as well. A study ...
(Date:6/30/2009)...nternational team of researchers has modified chlo...emely efficient light antennae of bacteria. The te...se light antennae. This is the first step to conve...f. The researchers will be publishing an article o...ion of the PNAS journal in the week starting 29 ...
(Date:6/30/2009)...THLEHEM, Pa. and NEWTON, Mass., June 30 /PRNewswir...Microfluidics International Corporation (OTC Bulle... have formed a strategic alliance to help biopharm... reliable nanotechnology and formulation methods a...ive Pharmaceutical Ingredients (APIs). , , Part...
Breaking Biology Technology:Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 2Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 3Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 4Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 5Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 6Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 7Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 8Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 2Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 3Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 4First step to converting solar energy using 'artificial leaf' 2Particle Sciences and Microfluidics Collaborate to Share Formulation and Nanotechnology Expertise for Pharmaceutical Drug Product Development, Analysis and Commercialization 2Particle Sciences and Microfluidics Collaborate to Share Formulation and Nanotechnology Expertise for Pharmaceutical Drug Product Development, Analysis and Commercialization 3
...s. API Software, Inc. announced Thursday the ava...o allow health care organization employees to bid ...pay schedule. , ,APIs shift-bidding module is exp...hat the Association of Nursing Executives consider...loyee recruiting and retention. , ,After a work pe...
...ogle, the ubiquitous Internet search engine compan...ent of its intention to go public. In doing so it ... had Wall Street drooling and its competition fidg...ny and its founders for being arrogant, secretive ...its stock offering. While some trepidation is unde...
...o years ago, 10 students working as scientists, bu...ingle goal: to become leaders in this state,s burg..., they will graduate as the first alumni of the m...University of Wisconsin-Madison. , ,Many biotechno...ls and contacts the students picked up during thei...
...mmon sense in project management isnt always so co...ath-project scheduling, most projects are still la...sed. Whats the problem? What should we do? After t...t enough time to complete it; that the estimates f...hen you research and analyze the facts, the conclu...
Other Biology Technology:Why Google Matters 2Why Google Matters 3First graduates boon to Wisconsin biotechnology 2First graduates boon to Wisconsin biotechnology 3First graduates boon to Wisconsin biotechnology 4Part 3 Project performance Get on the path to continuous improvement 2Part 3 Project performance Get on the path to continuous improvement 3
(Date:7/1/2009)...ds: For the first time, scientists have shown that...n 90% of IVF embryos, even those produced by young...ent in the Centre for Human Genetics and the Unive..., told the 25th annual conference of the European ... (Wednesday July 1), that the surprising finding m...
(Date:6/30/2009)...ontemporaries postulated that food consumption in ...that is, animals would eat as much as they could w...ing as this would allow them to. However, recent ...t, energy intake reaches a limit, even in animals ...les. Scientists at the Research Institute of Wildl...
(Date:6/30/2009)...ential of forest biotechnology to help address sig..."strangled at birth" by the rigid opposition of so...e even the testing of genetically modified trees, ...e taken to create a regulatory environment that co..., case-by-case basis, and is focused on the end pr...
(Date:6/30/2009)...tics yet, according to a new study 1 which shows ...he difference between ,good, and ,bad, paintings. ...University in Japan, pigeons use both color and pa...ed by humans, as well as their texture. Professor... Springer,s journal, Animal Cognition . , The c...
Breaking Biology News(10 mins):Chromosomal problems affect nearly all human embryos 2Chromosomal problems affect nearly all human embryos 3Key to evolutionary fitness: Cut the calories 2Anti-biotech groups obstruct forest biotechnology 2Anti-biotech groups obstruct forest biotechnology 3A bird's eye view of art 2MedCath Enters Definitive Agreement to Sell Dayton Heart Hospital to Good Samaritan Hospital Dayton 14935 1MedCath Enters Definitive Agreement to Sell Dayton Heart Hospital to Good Samaritan Hospital Dayton 14935 2MedCath Enters Definitive Agreement to Sell Dayton Heart Hospital to Good Samaritan Hospital Dayton 14935 3BioMS Medical to present at BioCentury Conference 4140 1BioMS Medical to present at BioCentury Conference 4140 2TB Drug Treatment Can Lead to Severe Pneumonia 14931 1TB Drug Treatment Can Lead to Severe Pneumonia 14931 2Corals addiction to junk food 2590 1Corals addiction to junk food 2590 2Corals addiction to junk food 2590 3
...nt subtypes of avian flu viruses shows that resist...rs worldwide, but is especially prevalent in China...iral drug amantadine is spreading more rapidly amo...heast Asia than in North America, according to the...s Research Hospital. , The St. Jude team reached ...
...ion System will provide valuable information for a... Katrina. The National Institute of Environmental ...tutes of Health, created the website to provide th... workers on contaminants in flood waters, infrastr...nformation for local populations. , The NIEHS Hu...
...ty researchers have identified some of the key fac...d by multiple sclerosis (MS), complications of pre...he findings offer important clues about why the ne...ys that at least some forms of brain damage could ...st edition of the scientific journal Nature Medici...
...nter new cells was likely stolen from a host cell ...yce Thompson Institute (BTI) at Cornell University...viruses, a group of viruses that can liquefy their... so much as a sneeze in mammals, as potential pest...be effective since they kill insects more slowly t...
Other Biology News:Drug resistant avian influenza viruses more common in Southeast Asia than North America 2Drug resistant avian influenza viruses more common in Southeast Asia than North America 3Drug resistant avian influenza viruses more common in Southeast Asia than North America 4FDA approves child-friendly AIDS medicine 2Molecular Partners Required For Appropriate Neuronal Gene Repression 2Molecular Partners Required For Appropriate Neuronal Gene Repression 3Molecular Partners Required For Appropriate Neuronal Gene Repression 4Stolen gene allows insect virus to enter cells 2Stolen gene allows insect virus to enter cells 3
MMP-2 / MMP-9 Inhibitor IV is a potent, selective, slow binding and mechanism based inhibitor of human gelatinases. • Molecular weight: 306.4 • Molecular Formula: C(15)H(14)O(3)S(2). &bul
Mucin 3 (MUC3) is a glycoprotein. distributed in colon and rectum, and to a lesser extent in breast, lung and salivary gland tissues. Comments: Ab-2 shows no cross-reaction with MUC1 and MUC2. E
Flat bottoms,• Nonreversible lids with condensation rings to reduce contamination,• Individual alphanumerical codes for well identification,• Uniform footprint for ease in stacking,&bu
Rabbit polyclonal to GABA A Receptor gamma 2 ( Abpromise for all tested applications). entrezGeneID: 2566 SwissProtID: P18507
Biology Products: